Tweenvest Stocks

CARGO Therapeutics, Inc. (NasdaqGM: CRGX)

Health Care · Biotechnology · US

$—

— today · — 1Y

CARGO Therapeutics, Inc. (NasdaqGM: CRGX) operates in the Biotechnology industry within the Health Care sector.

Tweenvest scores CARGO Therapeutics, Inc. across four factors: quality 47/100, value 44/100. Its strongest factor is quality.

CRGX price history

Not enough price history to draw a chart yet.

Key figures

Market cap
—
Revenue (TTM)
—
P/E
—
EPS
-4.63
Dividend yield
—
Beta (5Y)
—
52-week high
$—
52-week low
$—
Avg volume (3M)
—
Shares outstanding
—
Employees
167
Next earnings
—

About CARGO Therapeutics, Inc.

CARGO Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to pioneering innovative chimeric antigen receptor (CAR) T-cell therapies for patients battling cancer. Its primary therapeutic candidate is CRG-022, an autologous CD22 CAR T-cell product. This therapy is specifically engineered to counteract mechanisms of resistance in B-cell malignancies by targeting CD22, a distinct tumor antigen prevalent in these conditions. The company's pipeline also includes CRG-023, a novel tri-specific CAR T product candidate designed to engage tumor cells through three different B-cell antigen targets. Formerly known as Syncopation Life Sciences, Inc., the company adopted its current name, CARGO Therapeutics, Inc., in September 2022. Established in 2019, CARGO Therapeutics is headquartered in San Mateo, California.

ISIN
US14179K1016
Founded
2019
Listed since
Nov 13, 2023
Exchange
Nasdaq Global Market
Currency
USD
CompanyMarket capPriceDay
PhaseRx, Inc.OTCPK: PZRX.Q$12.00$——
ContraFect CorporationOTCPK: CFRX.Q$11.00$0.00—
Notable Labs, Ltd.OTCPK: NTBL.Q$10.00$——
OncoSec Medical IncorporatedOTCPK: ONCS.Q$6.00$0.00—
Calithera Biosciences, Inc.OTCPK: CALA$5.00$0.00-99.00%
Biocept, Inc.OTCPK: BIOC.Q$3.00$0.00-99.50%
Yield10 Bioscience, Inc.OTCPK: YTEN.Q$1.00$——
LadRx CorporationOTCPK: LADX$0.00$0.00-99.50%

Browse every Biotechnology company →

Figures last refreshed Oct 18, 2026.